Manulife (Manufacturers Life Insurance)’s Monte Rosa Therapeutics GLUE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $540K | Buy |
119,836
+2,529
| +2% | +$11.4K | ﹤0.01% | 2147 |
|
2025
Q1 | $544K | Sell |
117,307
-105
| -0.1% | -$487 | ﹤0.01% | 2103 |
|
2024
Q4 | $815K | Sell |
117,412
-465
| -0.4% | -$3.23K | ﹤0.01% | 2000 |
|
2024
Q3 | $625K | Buy |
117,877
+15,168
| +15% | +$80.4K | ﹤0.01% | 2164 |
|
2024
Q2 | $384K | Sell |
102,709
-378
| -0.4% | -$1.41K | ﹤0.01% | 2316 |
|
2024
Q1 | $727K | Sell |
103,087
-1,456
| -1% | -$10.3K | ﹤0.01% | 2034 |
|
2023
Q4 | $591K | Hold |
104,543
| – | – | ﹤0.01% | 2102 |
|
2023
Q3 | $501K | Buy |
104,543
+26
| +0% | +$125 | ﹤0.01% | 2141 |
|
2023
Q2 | $716K | Buy |
104,517
+1,267
| +1% | +$8.68K | ﹤0.01% | 1830 |
|
2023
Q1 | $804K | Hold |
103,250
| – | – | ﹤0.01% | 1732 |
|
2022
Q4 | $759K | Sell |
103,250
-99
| -0.1% | -$728 | ﹤0.01% | 1744 |
|
2022
Q3 | $814K | Sell |
103,349
-556
| -0.5% | -$4.38K | ﹤0.01% | 1697 |
|
2022
Q2 | $1.02M | Buy |
103,905
+11,688
| +13% | +$114K | ﹤0.01% | 1640 |
|
2022
Q1 | $1.26M | Buy |
+92,217
| New | +$1.26M | ﹤0.01% | 1648 |
|